Pharmacovigilance of quality deviations in the public healthcare system
Drug quality deviation (DQD) is the disagreement with the parameters at the registration with after commercialization step. Pharmacovigilance programs should be notified of DQD to ensure drug efficacy and support patient safety. Objective: To describe DQD from public healthcare system and its im...
Guardado en:
Autores principales: | Carolina Resende Bitencourt, Cristiane Aparecida Menezes De Pádua, Paula Lana De Miranda Drummond, Edson Perini |
---|---|
Formato: | article |
Lenguaje: | EN PT |
Publicado: |
Sociedade Brasileira de Farmácia Hospitalar e Serviços de Saúde
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/b5da99e20a1c4a8a97b339708dbc50ab |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Evidence-based Appraisal of the CARAVAGGIO Trial
por: Tiffany Khieu, et al.
Publicado: (2021) -
Type 2 Diabetes Mellitus in Patients with a Prior History of Corticosteroid-induced Hyperglycemia
por: Jennifer Levine DeZubay, et al.
Publicado: (2019) -
A proposal for pharmacovigilance data restructuring at the teaching hospital
por: Sayuri R. Yamashita, et al.
Publicado: (2020) -
Guest editorial: The ten most important qualities for the profession of medicinal research
por: Tony Y. Zhang
Publicado: (2021) -
Correction: Structural Racism and Supporting Black Lives – A Pharmacist’s Vow amid COVID-19
por: Nicole D. Avant
Publicado: (2021)